Literature DB >> 27208176

miR-30a can inhibit DNA replication by targeting RPA1 thus slowing cancer cell proliferation.

Zhenyou Zou1, Mengjie Ni2, Jing Zhang3, Yongfeng Chen2, Hongyu Ma4, Shihan Qian2, Longhua Tang2, Jiamei Tang2, Hailun Yao2, Chengbin Zhao2, Xiongwen Lu2, Hongyang Sun2, Jue Qian2, Xiaoting Mao2, Xulin Lu2, Qun Liu2, Juping Zen2, Hanbing Wu2, Zhaosheng Bao2, Shudan Lin2, Hongyu Sheng2, Yunlong Li2, Yong Liang2, Zhiqiang Chen2, Dan Zong2.   

Abstract

Cell proliferation was inhibited following forced over-expression of miR-30a in the ovary cancer cell line A2780DX5 and the gastric cancer cell line SGC7901R. Interestingly, miR-30a targets the DNA replication protein RPA1, hinders the replication of DNA and induces DNA fragmentation. Furthermore, ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) were phosphorylated after DNA damage, which induced p53 expression, thus triggering the S-phase checkpoint, arresting cell cycle progression and ultimately initiating cancer cell apoptosis. Therefore, forced miR-30a over-expression in cancer cells can be a potential way to inhibit tumour development.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  DNA replication; RPA1; S-phase checkpoint; cell cycle arrest; miR-30a

Mesh:

Substances:

Year:  2016        PMID: 27208176     DOI: 10.1042/BCJ20160177

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells.

Authors:  Yueh-Hua Chung; Sung-Chou Li; Ying-Hsien Kao; Hao-Lun Luo; Yuan-Tso Cheng; Pey-Ru Lin; Ming-Hong Tai; Po-Hui Chiang
Journal:  Int J Mol Sci       Date:  2017-08-22       Impact factor: 5.923

2.  miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM.

Authors:  Yuyan Guo; Wenze Sun; Tuotuo Gong; Yanlan Chai; Juan Wang; Beina Hui; Yi Li; Liping Song; Ying Gao
Journal:  Oncol Rep       Date:  2017-02-14       Impact factor: 3.906

3.  miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis.

Authors:  Songzi Zhang; Huizhu Liu; Yuxia Liu; Jie Zhang; Hongbo Li; Weili Liu; Guohong Cao; Pan Xv; Jinjin Zhang; Changjun Lv; Xiaodong Song
Journal:  Int J Mol Sci       Date:  2017-03-15       Impact factor: 5.923

4.  Bioinformatics prediction of miR-30a targets and its inhibition of cell proliferation of osteosarcoma by up-regulating the expression of PTEN.

Authors:  Biao Zhong; Shang Guo; Wei Zhang; Chi Zhang; Yukai Wang; Changqing Zhang
Journal:  BMC Med Genomics       Date:  2017-11-15       Impact factor: 3.063

5.  MiR-30a-5p inhibits proliferation and metastasis of hydatidiform mole by regulating B3GNT5 through ERK/AKT pathways.

Authors:  Zhenzhen Guo; Qiannan Sun; Yangyou Liao; Chao Liu; Wenjie Zhao; Xiaoxue Li; Huan Liu; Ming Dong; Yuhong Shang; Linlin Sui; Ying Kong
Journal:  J Cell Mol Med       Date:  2020-06-23       Impact factor: 5.310

Review 6.  MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer.

Authors:  Lin-Hong Jiang; He-da Zhang; Jin-Hai Tang
Journal:  J Oncol       Date:  2018-08-06       Impact factor: 4.375

7.  Genetic Variations in miR-30 Family Member Regulatory Regions Are Associated with Breast Cancer Risk in a Chinese Population.

Authors:  Jing Zhou; Lijuan Wang; Sijun Liu; Wen Zhou; Yue Jiang; Jiangbo Du; Juncheng Dai; Guangfu Jin; Hongxia Ma; Zhibin Hu; Jiaping Chen; Hongbing Shen
Journal:  Biomed Res Int       Date:  2020-03-27       Impact factor: 3.411

8.  Germline Polymorphisms and Length of Survival of Nasopharyngeal Carcinoma: An Exome-Wide Association Study in Multiple Cohorts.

Authors:  Yun-Miao Guo; Jie-Rong Chen; Yan-Chun Feng; Melvin L K Chua; Yanni Zeng; Edwin Pun Hui; Allen K C Chan; Lin-Quan Tang; Lin Wang; Qian Cui; Hui-Qiong Han; Chun-Ling Luo; Guo-Wang Lin; Yan Liang; Yang Liu; Zhong-Lian He; Yu-Xiang Liu; Pan-Pan Wei; Chu-Jun Liu; Wan Peng; Bo-Wei Han; Xiao-Yu Zuo; Enya H W Ong; Eugenia L L Yeo; Kar Perng Low; Gek San Tan; Tony K H Lim; Jacqueline S G Hwang; Bo Li; Qi-Sheng Feng; Xiaojun Xia; Yun-Fei Xia; Josephine Ko; Wei Dai; Maria L Lung; Anthony T C Chan; Dennis Y M Lo; Mu-Sheng Zeng; Hai-Qiang Mai; Jianjun Liu; Yi-Xin Zeng; Jin-Xin Bei
Journal:  Adv Sci (Weinh)       Date:  2020-03-20       Impact factor: 16.806

9.  miR-30a targets STOX2 to increase cell proliferation and metastasis in hydatidiform moles via ERK, AKT, and P38 signaling pathways.

Authors:  Zhenzhen Guo; Chenyu Zhu; Ying Kong; Dong Li; Linlin Sui; Youhui Wang; Zhen Li; Lu Wang; Jianhui Fan; Yuefei Xu; Na Zou
Journal:  Cancer Cell Int       Date:  2022-03-04       Impact factor: 5.722

10.  Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1.

Authors:  Zhongya Ni; Chao Yao; Xiaowen Zhu; Chenyuan Gong; Zihang Xu; Lixin Wang; Suyun Li; Chunpu Zou; Shiguo Zhu
Journal:  Br J Cancer       Date:  2017-10-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.